Biocon appoints Suresh Subramanian as chief of brand formulations

19 September, Bengaluru

Pharma major Biocon Ltd Monday announced appointment of Suresh Subramanian as Senior Vice president and Head of the Company’s Branded Formulations (India) business.

Subramanian has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer. Over theyears, he has played multiple leadership roles in Business Development, Marketing, Sales and Strategy. He has a rich experience of multiple product launches, business optimization, cost control, talent development and performance management.

He had managed a wide portfolio spanning diverse therapy areas such as Neurosciences, Respiratory, Cardiology, Oncology, Critical Care, Gastro-Intestinal, Ophthalmology, Pain & Inflammation andWomen’s Health in the Indian market. He has also played a critical role in mapping the pharma opportunity in India as part of the Steering Committee for McKinsey’s India Pharma 2020 report, a company statement said.

Biocon, CMD Kiran Mazumdar-Shawsaid Suresh had deep expertise in diverse therapy areas including Oncology, Cardiology and Critical Care and has a proven track record of delivering robust businessgrowth.

”We are sure, under his leadership, our Branded Formulations business will evolve further and become a strong value builder for Biocon,” she said.

Biocon’s Branded Formulations (India) business is a biologics-led, specialty pharma business focused on the chronic therapy areas of diabetes, cancer and autoimmune conditions. Many of its key brands are leaders in their respective categories.